Holen Sie sich die Stockscreener-App
2.8009
4.87%
0.1309
Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes - Quantisnow
Adc Therapeutics SA (NYSE: ADCT) Continues Its Downward Trend - Stocksregister
ADC Therapeutics Announces Updated ZYNLONTA Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma - marketscreener.com
ZYNLONTA shows 85% response rate in marginal zone lymphoma trial By Investing.com - Investing.com Nigeria
ZYNLONTA shows 85% response rate in marginal zone lymphoma trial - Investing.com Australia
Breakthrough Lymphoma Treatment: ZYNLONTA Shows 85% Response Rate with 27-Month Durability in Latest Trial - Stock Titan
Switzerland: ADC Therapeutics raises US$100m from PIPE financing - Investors in Healthcare
ADC Therapeutics (NYSE:ADCT) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World
Analysts Set Expectations for ADCT FY2026 Earnings - MarketBeat
Guggenheim Raises Price Target for ADC Therapeutics (ADCT) | ADCT Stock News - GuruFocus
ADC reports data from lymphoma trial, streamlines operations - MSN
ADC Therapeutics (ADCT) Price Target Raised Amid Strategic Moves - GuruFocus
ADC Therapeutics (ADCT) Secures $100M in PIPE Financing to Boost ZYNLONTA Development - GuruFocus
Layoff Tracker: ADC Therapeutics Cutting 30% of Staff, Closing London Research Facility - BioSpace
ADC Therapeutics (NYSE:ADCT) Price Target Raised to $10.00 at Guggenheim - MarketBeat
ADC Therapeutics price target raised to $10 from $7 on positive trial data By Investing.com - Investing.com South Africa
ADC Therapeutics announces $100M private financing - MSN
ADC Therapeutics price target raised to $10 from $7 on positive trial data - Investing.com India
ADC Therapeutics (ADCT) Price Target Raised Amid Strategic Moves | ADCT Stock News - GuruFocus
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress - The Malaysian Reserve
ADC Therapeutics raises $100 million in private placement By Investing.com - Investing.com South Africa
ZYNLONTA-glofitamab combo shows 93.3% response rate in lymphoma trial By Investing.com - Investing.com South Africa
ADC Therapeutics Tightens Belt And Targets New Frontiers - Finimize
Transcript : ADC Therapeutics SASpecial Call - MarketScreener
ADC Therapeutics Announces $100M Private Placement - TipRanks
ADC Therapeutics to Cut 30% of Workforce, Shutter UK Site - MarketScreener
ADC Therapeutics : Corporate and Clinical Update June 2025 - MarketScreener
ADC Therapeutics (ADCT) Secures $100 Million in Private Equity F - GuruFocus
Adc Therapeutics Announces Updated Data from Lotis-7 Clinical Trial Presented At the European Hematology Association 2025 Congress - MarketScreener
ADC Therapeutics (ADCT) Secures $100 Million in Private Equity Financing | ADCT Stock News - GuruFocus
ADC Therapeutics raises $100 million in private placement - Investing.com Australia
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028 - GuruFocus
Adc Therapeutics Announces $100 Mln Private Placement Extending Expected Cash Runway Into 2028 - marketscreener.com
ZYNLONTA-glofitamab combo shows 93.3% response rate in lymphoma trial - Investing.com
Wellington Management Group LLP Grows Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - MarketBeat
Equities Analysts Issue Forecasts for ADCT FY2026 Earnings - Defense World
Millennium Management LLC Sells 301,277 Shares of ADC Therapeutics SA (NYSE:ADCT) - MarketBeat
Two Sigma Investments LP Has $365,000 Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World
Two Sigma Advisers LP Grows Stake in ADC Therapeutics SA (NYSE:ADCT) - Defense World
Wellington Management Group LLP Purchases 84,785 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World
Squarepoint Ops LLC Increases Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World
ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript - MSN
Millennium Management LLC Decreases Stock Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World
Nuveen Asset Management LLC Purchases 22,989 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World
ADC Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
ProShare Advisors LLC Increases Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World
ADC Therapeutics SA (NYSE:ADCT) Shares Sold by Bank of America Corp DE - MarketBeat
ADC Therapeutics (ADCT) Shares Decline Amid Market Movement | AD - GuruFocus
Adc Therapeutics SA (NYSE: ADCT) Jumps 2.28%, Turning Investors Away - Stocksregister
ADC Therapeutics SA (NYSE:ADCT) Stock Position Boosted by Deutsche Bank AG - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World
0.99%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):